The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Tandem Meetings 2023 | Nursing track: pharmacy updates
Susie Long, PharmD, University of Minnesota Masonic Children’s Hospital, Minneapolis, MN, gives an overview of the key pharmacy updates that were presented at the Nursing Track at this year’s Tandem Meetings. Dr Long comments on gene therapy for adrenoleukodystrophy (ALD) and thalassemia, complement blockade for transplant-associated thrombotic microangiopathy (TA-TMA), novel therapies to prevent and treat cytomegalovirus (CMV) infection, and novel agents for thrombocytopenia. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
